These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20484354)

  • 1. GSK is accused of trying to suppress editorial on rosiglitazone.
    Tanne JH
    BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
    [No Abstract]   [Full Text] [Related]  

  • 2. Why the Avandia scandal proves big pharma needs stronger ethical standards.
    Philpott S; Baker R
    Bioethics; 2010 Oct; 24(8):ii-iii. PubMed ID: 21050246
    [No Abstract]   [Full Text] [Related]  

  • 3. Full disclosure.
    Maxwell D
    Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
    [No Abstract]   [Full Text] [Related]  

  • 4. Getting more generous with the truth: clinical trial reporting in 2013 and beyond.
    Barbour V; Clark J; Connell L; Ross A; Simpson P; Veitch E; Winker M
    PLoS Med; 2013; 10(1):e1001379. PubMed ID: 23382657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone: what went wrong?
    Cohen D
    BMJ; 2010 Sep; 341():c4848. PubMed ID: 20819889
    [No Abstract]   [Full Text] [Related]  

  • 6. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 7. European drug regulators publish their evaluation of rosiglitazone.
    Mayor S
    BMJ; 2010 Dec; 341():c7278. PubMed ID: 21169326
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 9. Faster publication isn't always better.
    Fuster V; Farkouh ME
    Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):345. PubMed ID: 17589426
    [No Abstract]   [Full Text] [Related]  

  • 10. Accuracy in publishing: where does the responsibility lie?
    Cowell JM
    J Sch Nurs; 2011 Oct; 27(5):324-7. PubMed ID: 21989133
    [No Abstract]   [Full Text] [Related]  

  • 11. Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
    Harv Heart Lett; 2007 Aug; 17(12):1-2. PubMed ID: 17717888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rosiglitazone].
    Johansen K
    Ugeskr Laeger; 2010 Sep; 172(38):2631; author reply 2631. PubMed ID: 20931733
    [No Abstract]   [Full Text] [Related]  

  • 13. Analytical issues regarding rosiglitazone meta-analysis.
    Claggett B; Wei LJ
    Arch Intern Med; 2011 Jan; 171(2):179-80; author reply 180. PubMed ID: 21263111
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA committee urges tight restrictions on rosiglitazone.
    Roehr B
    BMJ; 2010 Jul; 341():c3862. PubMed ID: 20639290
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA puts restrictions on use of controversial diabetes drug.
    Mayo Clin Womens Healthsource; 2011 Feb; 15(2):3. PubMed ID: 21200371
    [No Abstract]   [Full Text] [Related]  

  • 16. Authorship policy.
    Novack GD
    Am J Ophthalmol; 2009 Jan; 147(1):184; author reply 184-5. PubMed ID: 19100357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transparency in biomedical research: about the risks associated with the use of Avandia].
    Salas SP; Russo M
    Rev Med Chil; 2010 Sep; 138(9):1197-200. PubMed ID: 21249291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rosiglitazone--statistics for benefits and problems].
    Hjelmesaeth J; Røislien J
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2702-3. PubMed ID: 17952157
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone and cardiovascular disease revisited.
    Davis TM; Prins JB
    Med J Aust; 2010 Aug; 193(3):134-5. PubMed ID: 20678037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.